- Home
- BLKB vs SRPT Comparison
BLKB vs SRPT Comparison
Compare BLKB & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLKB | SRPT |
|---|---|---|
| Founded | 1981 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2004 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BLKB | SRPT |
|---|---|---|
| Price | $47.68 | $18.33 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 28 |
| Target Price | ★ $70.50 | $25.76 |
| AVG Volume (30 Days) | 402.8K | ★ 3.2M |
| Earning Date | 02-10-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,136,093,000.00 | ★ $2,413,715,000.00 |
| Revenue This Year | N/A | $14.46 |
| Revenue Next Year | $4.26 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.15 |
| 52 Week Low | $45.81 | $10.42 |
| 52 Week High | $81.39 | $114.41 |
Technical Indicators
Market Signals| Indicator | BLKB | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 26.57 | 38.15 |
| Support Level | $45.81 | $16.90 |
| Resistance Level | $55.53 | $21.36 |
| Average True Range (ATR) | 2.78 | 1.35 |
| MACD | -0.62 | -0.37 |
| Stochastic Oscillator | 8.67 | 18.30 |
Price Performance
Historical ComparisonAbout BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.